Rajesh Malik - 15 Dec 2022 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Chief Medical Officer
Signature
/s/ James Stillman Hanson, attorney-in-fact
Issuer symbol
GTHX
Transactions as of
15 Dec 2022
Transactions value $
$4,200
Form type
4
Filing time
16 Dec 2022, 15:12:26 UTC
Previous filing
28 Nov 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Options Exercise $4,200 +14,000 +19% $0.3 87,207 15 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Option (Right to Buy) Options Exercise $0 -14,000 -25% $0 41,000 15 Dec 2022 Common Stock 14,000 $0.3 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents (i) 68,332 shares of common stock; (ii) 6,875 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
F2 All shares underlying this option have vested.